Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

_____ Brought to you by Agilent Technologies _____

Accurate Determination of Trace Nitrosamines in Sartan, Ranitidine and Metformin Based Drugs

REGISTER NOW

 

  October 20, 2020

  8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST

 

Overview

 

Several sartan, ranitidine and metformin-based drug products were recently recalled due to the presence of unacceptable amounts of mutagenic nitrosamine impurities. The USFDA and other regulatory agencies have provided analytical testing guidance for the evaluation of trace nitrosamine impurities in these drug substances and drug products. Consequently, API and drug product manufacturers are under increased pressure to accurately identify and quantify mutagenic impurities in APIs and drug products.

In this presentation, we will present the relevant GC/MS and LC/MS based analytical strategies to accurately detect and quantify nitrosamines in sartan, ranitidine, and metformin-based drugs.

Register now for the previous webinar in the series, live October 15, 2020, available on demand after October 16: Analysis of Nitrosamine Impurities in Pharmaceuticals – Current challenges and future perspectives

Brought to you by:

 

Key Learning Objectives

  • Understand what mutagenic impurities are and why it's important to characterize and quantify them, even when present in trace amounts
  • Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs
  • Learn about approaches for the confident identification and quantification of nitrosamines in APIs and drugs

Who Should Attend

  • Laboratory managers
  • Chromatographers
  • Analytical chemists and scientists
  • New product developers
  • Pharma quality control manager
 

Speakers

Soma Dasgupta, Ph.D.
Application Engineer, GC/GCMS,
Agilent Technologies
Chander Mani
Application Engineer,
Agilent Technologies
Kartheek Srinivas Chidella
Application Engineer,
Agilent Technologies
 

Moderator

Kelly McSweeney
Contributing Editor,
C&EN Media Group
 

REGISTER NOW